Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
Dall'Olio FG, Parisi C, Marcolin L, Brocchi S, Caramella C, Conci N, Carpani G, Gelsomino F, Ardizzoni S, Marchese PV, Paccapelo A, Grilli G, Golfieri R, Besse B, Ardizzoni A.
Dall'Olio FG, et al. Among authors: marchese pv.
Ther Adv Med Oncol. 2022 Feb 12;14:17588359211058391. doi: 10.1177/17588359211058391. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 35173818
Free PMC article.